J. Fennell

发表

Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis.

H. Drummond, E. Nimmo, J. Satsangi, 2005, Gastroenterology.

Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgery

R. Prescott, J. Satsangi, C. Mowat, 2004, Alimentary pharmacology & therapeutics.

NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?

H. Drummond, E. Nimmo, J. Satsangi, 2004, Genes and Immunity.

Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry

C. Sandborg, R. Schneider, R. Sundel, 2022, Pediatric Rheumatology.

The safety profile of anti‐tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient‐years follow‐up

C. Lees, J. Satsangi, R. Forsythe, 2009, Alimentary pharmacology & therapeutics.

Anti-TNF-α therapy for orofacial granulomatosis: proceed with caution

J. Satsangi, D. Gaya, J. Fennell, 2006, Gut.

Anti-TNF-alpha therapy for orofacial granulomatosis

J. Satsangi, D. Gaya, J. Fennell, 2006 .

The use of adalimumab in the management of refractory Crohn’s disease

C. Lees, J. Satsangi, I. Arnott, 2007, Alimentary pharmacology & therapeutics.

Theexpression ofCD18 isincreased on Trisomy21 (Downsyndrome) lymphoblastoid cells

J. Fennell, Amanda L. Williams, 1988 .

The expression of CD18 is increased on Trisomy 21 (Down syndrome) lymphoblastoid cells.

G. M. Taylor, D. Donnai, J. Fennell, 1988, Clinical and experimental immunology.

Predicting outcome and risk assessment in severe ulcerative colitis

R. Prescott, J. Satsangi, C. Mowat, 2003 .

Anti-TNF-alpha therapy for orofacial granulomatosis: proceed with caution.

J. Satsangi, D. Gaya, J. Fennell, 2006, Gut.

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry

C. Sandborg, L. McAllister, Y. Zhang, 2021, Pediatric Rheumatology.

Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study

G. Tomlinson, C. Sandborg, L. McAllister, 2021, Arthritis & rheumatology.

Anti-TNF-α therapy for orofacial granulomatosis: proceed with caution

K. Chu, D. Gaya, J. Fennell, 2006, Gut.